AAAAAA
Results: 26-50/60
Authors:
Robbins, RJ
Hill, RH
Wang, WP
Macapinlac, HH
Larson, SM
Citation: Rj. Robbins et al., Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogue, THYROID, 10(2), 2000, pp. 177-183
Authors:
Larson, SM
Davidson, AR
Citation: Sm. Larson et Ar. Davidson, The identification of conserved interactions within the SH3 domain by alignment of sequences and structures, PROTEIN SCI, 9(11), 2000, pp. 2170-2180
Authors:
Nunez, RF
Yeung, HWD
Macapinlac, HA
Castro-Malaspina, H
Larson, SM
Citation: Rf. Nunez et al., Ga-67 uptake in cutaneous lesions of graft-versus-host disease, CLIN NUCL M, 25(9), 2000, pp. 676-678
Authors:
Erdi, YE
Macapinlac, H
Rosenzweig, KE
Humm, JL
Larson, SM
Erdi, AK
Yorke, ED
Citation: Ye. Erdi et al., Use of PET to monitor the response of lung cancer to radiation treatment, EUR J NUCL, 27(7), 2000, pp. 861-866
Authors:
Yeung, HWD
Humm, JL
Larson, SM
Citation: Hwd. Yeung et al., Radioiodine uptake in thyroid remnants during therapy after tracer dosimetry, J NUCL MED, 41(6), 2000, pp. 1082-1085
Authors:
Levchenko, A
Mehta, BM
Lee, JB
Humm, JL
Augensen, F
Squire, O
Kothari, PJ
Finn, RD
Leonard, EF
Larson, SM
Citation: A. Levchenko et al., Evaluation of C-11-colchicine for PET imaging of multiple drug resistance, J NUCL MED, 41(3), 2000, pp. 493-501
Authors:
Ruan, S
O'Donoghue, JA
Larson, SM
Finn, RD
Jungbluth, A
Welt, S
Humm, JL
Citation: S. Ruan et al., Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam, J NUCL MED, 41(11), 2000, pp. 1905-1912
Authors:
Kramer, K
Cheung, NKV
Humm, JL
Dantis, E
Finn, R
Yeh, SJ
Antunes, NL
Dunker, IJ
Souwedaine, M
Larson, SM
Citation: K. Kramer et al., Targeted radioimmunotherapy for leptomeningeal cancer using I-131-3F8, MED PED ONC, 35(6), 2000, pp. 716-718
Authors:
DiResta, GR
Lee, J
Healey, JH
Levchenko, A
Larson, SM
Arbit, E
Citation: Gr. Diresta et al., "Artificial lymphatic system": A new approach to reduce interstitial hypertension and increase blood flow, pH and pO(2) in solid tumors, ANN BIOMED, 28(5), 2000, pp. 543-555
Authors:
DiResta, GR
Lee, J
Healey, JH
Larson, SM
Arbit, E
Citation: Gr. Diresta et al., Enhancing the uptake of chemotherapeutic drugs into tumors using an "artificial lymphatic system", ANN BIOMED, 28(5), 2000, pp. 556-564
Authors:
Larson, SM
Di Nardo, AA
Davidson, AR
Citation: Sm. Larson et al., Analysis of covariation in an SH3 domain sequence alignment: Applications in tertiary contact prediction and the design of compensating hydrophobic core substitutions, J MOL BIOL, 303(3), 2000, pp. 433-446
Authors:
Wang, WP
Larson, SM
Fazzari, M
Tickoo, SK
Kolbert, K
Sgouros, G
Yeung, H
Macapinlac, H
Rosai, J
Robbins, RJ
Citation: Wp. Wang et al., Prognostic value of [F-18]fluorodeoxyglucose positron emission tomographicscanning in patients with thyroid cancer, J CLIN END, 85(3), 2000, pp. 1107-1113
Authors:
Jarvis, KS
Vilas, F
Larson, SM
Gaffey, MJ
Citation: Ks. Jarvis et al., Are Hyperion and Phoebe linked to Lapetus?, ICARUS, 146(1), 2000, pp. 125-132
Authors:
Jarvis, KS
Vilas, F
Larson, SM
Gaffey, MJ
Citation: Ks. Jarvis et al., JVI Himalia: New compositional evidence and interpretations for the originof Jupiter's small satellites, ICARUS, 145(2), 2000, pp. 445-453
Authors:
Tickoo, SK
Pittas, AG
Adler, M
Fazzari, M
Larson, SM
Robbins, RJ
Rosai, J
Citation: Sk. Tickoo et al., Bone metastases from thyroid carcinoma - A histopathologic study with clinical correlates, ARCH PATH L, 124(10), 2000, pp. 1440-1447
Authors:
Reuland, P
Larson, SM
Citation: P. Reuland et Sm. Larson, Endocrine/neuroendocrine tumors, PET IN CLINICAL ONCOLOGY, 2000, pp. 345-354
Authors:
Omar, AH
Biegalski, S
Larson, SM
Landsberger, S
Citation: Ah. Omar et al., Particulate contributions to light extinction and local forcing at a ruralIllinois site, ATMOS ENVIR, 33(17), 1999, pp. 2637-2646
Authors:
Hitzenberger, R
Berner, A
Giebl, H
Kromp, R
Larson, SM
Rouc, A
Koch, A
Marischka, S
Puxbaum, H
Citation: R. Hitzenberger et al., Contribution of carbonaceous material to cloud condensation nuclei concentrations in European background (Mt. Sonnblick) and urban (Vienna) aerosols, ATMOS ENVIR, 33(17), 1999, pp. 2647-2659
Authors:
Hitzenberger, R
Jennings, SG
Larson, SM
Dillner, A
Cachier, H
Galambos, Z
Rouc, A
Spain, TG
Citation: R. Hitzenberger et al., Intercomparison of measurement methods for black carbon aerosols, ATMOS ENVIR, 33(17), 1999, pp. 2823-2833
Authors:
Graham, MC
Scher, HI
Liu, GB
Yeh, SDJ
Curley, T
Daghighian, F
Goldsmith, SJ
Larson, SM
Citation: Mc. Graham et al., Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases front androgen-independent prostate cancer, CLIN CANC R, 5(6), 1999, pp. 1307-1318
Authors:
Chaudhry, A
Carrasquillo, JA
Avis, IL
Shuke, N
Reynolds, JC
Bartholomew, R
Larson, SM
Cuttitta, F
Johnson, BE
Mulshine, JL
Citation: A. Chaudhry et al., Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer, CLIN CANC R, 5(11), 1999, pp. 3385-3393
Authors:
Fonti, R
Cheung, NKV
Bridger, GJ
Guo, HF
Abrams, MJ
Larson, SM
Citation: R. Fonti et al., Tc-99m-Monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors, NUCL MED BI, 26(6), 1999, pp. 681-686
Authors:
Fonti, R
Levchenko, A
Mehta, BM
Zhang, JJ
Tsuruo, T
Larson, SM
Citation: R. Fonti et al., Measurement of P-glycoprotein expression in human neuroblastoma xenograftsusing in vitro quantitative autoradiography, NUCL MED BI, 26(1), 1999, pp. 35-41
Authors:
Sabbatini, P
Larson, SM
Kremer, A
Zhang, ZF
Sun, M
Yeung, H
Imbriaco, M
Horak, I
Conolly, M
Ding, C
Ouyang, P
Kelly, WK
Scher, HI
Citation: P. Sabbatini et al., Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer, J CL ONCOL, 17(3), 1999, pp. 948-957
Authors:
Sgouros, G
Ballangrud, AM
Jurcic, JG
McDevitt, MR
Humm, JL
Erdi, YE
Mehta, BM
Finn, RD
Larson, SM
Scheinberg, DA
Citation: G. Sgouros et al., Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: Bi-213-HuM195 (anti-CD33) in patients with leukemia, J NUCL MED, 40(11), 1999, pp. 1935-1946